Rezpegaldesleukin
瑞培仑白介素-2
Report date: 2026/04/03 20:03:44
Base Information
Drug NameRezpegaldesleukin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[29]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesNektar Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesNektar TherapeuticsEli Lilly And CompanyNational Institute Of Diabetes And Digestive And Kidney Diseases
Inactive CompaniesLilly Suzhou Pharmaceutical Co Ltd
Active Indications +[5]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A